CLDX · Celldex Therapeutics, Inc. · Executive Compensation
$28.03
+0.48 (+1.72%)
At close · Nov 19
Return incl. dividend (before tax)
Q4 2021 earnings call transcript
Market Cap
$2.16B
Shares
78.55M
Volume · Nov 19
75.61K
Avg daily vol (3M)
1.33M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
Leadership
- Anthony Marucci CEO, Board Member
- Anthony S. Marucci CEO, Board Member
- Harry H. Penner, Jr. Chairman, Board Member
- Karen L. Shoos Chairman
- Freddy A. Jimenez, Esq. General Counsel
- Freddy Jimenez General Counsel
- Cheryl L. Cohen Board Member
- Denice Torres Board Member
- Garry A. Neil, M.D. Board Member
- Herbert J. Conrad Board Member
- James J. Marino Board Member
- Keith L. Brownlie Board Member
- Rita I. Jain, M.D. Board Member
- Rita Jain, M.D. Board Member
Key facts
CIK
744218
CUSIP
15117B202
13F (30d)
267 filings
239 filers
Visit website
Investor relations